ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,091,000 | +513.2% | 25,250 | +389.9% | 0.19% | +551.7% |
| Q1 2021 | $341,000 | -67.1% | 5,154 | -61.9% | 0.03% | -65.5% |
| Q4 2020 | $1,037,000 | -43.8% | 13,516 | -68.5% | 0.08% | -47.8% |
| Q3 2020 | $1,845,000 | +22.4% | 42,864 | +22.8% | 0.16% | +3.9% |
| Q2 2020 | $1,507,000 | -65.2% | 34,893 | -76.8% | 0.16% | -67.2% |
| Q1 2020 | $4,327,000 | +23.3% | 150,401 | +171.9% | 0.47% | +345.3% |
| Q4 2019 | $3,508,000 | +15.6% | 55,315 | -51.7% | 0.11% | -10.2% |
| Q2 2019 | $3,034,000 | +68.7% | 114,504 | +16.8% | 0.12% | +13.5% |
| Q1 2019 | $1,798,000 | +785.7% | 98,005 | +77.2% | 0.10% | +3366.7% |
| Q4 2017 | $203,000 | +866.7% | 55,300 | +385.1% | 0.00% | – |
| Q1 2017 | $21,000 | -80.2% | 11,400 | -83.5% | 0.00% | -100.0% |
| Q4 2016 | $106,000 | -10.2% | 68,900 | +328.0% | 0.00% | -25.0% |
| Q3 2016 | $118,000 | -10.6% | 16,100 | -35.3% | 0.00% | -33.3% |
| Q2 2016 | $132,000 | – | 24,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |